Rankings
▼
Calendar
VTRS Q4 2023 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena
VTRS
Viatris Inc.
$17B
Q4 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$3.8B
-1.0% YoY
Gross Profit
$1.6B
41.6% margin
Operating Income
-$455M
-11.8% margin
Net Income
-$766M
-20.0% margin
EPS (Diluted)
$-0.64
QoQ Revenue Growth
-2.7%
Cash Flow
Operating Cash Flow
$479M
Free Cash Flow
$279M
Stock-Based Comp.
$56M
Balance Sheet
Total Assets
$47.7B
Total Liabilities
$27.2B
Stockholders' Equity
$20.5B
Cash & Equivalents
$992M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.8B
$3.9B
-1.0%
Gross Profit
$1.6B
$1.3B
+25.3%
Operating Income
-$455M
-$201M
-125.8%
Net Income
-$766M
$1.0B
-175.7%
Revenue Segments
Brands
$2.4B
56%
Generics
$1.9B
44%
Geographic Segments
Developed Markets Segment
$2.3B
61%
Emerging Markets Segment
$619M
16%
Greater China Segment
$515M
13%
Japan, Australia and New Zealand Segment
$372M
10%
← FY 2023
All Quarters
Q1 2024 →